Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM
Clearside Biomedical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.33M | 306K | 1.04M | 90K | 230K | 6.34M | 859K | 1.02M | 4K | 330K | 266K | 384K | 347K | 25.69M | 3.07M | 780K | 34K |
Cost of Revenue | 248K | 149K | n/a | n/a | 28K | 20K | 142K | 213K | n/a | 204K | n/a | 38K | n/a | 3.89M | n/a | n/a | n/a |
Gross Profit | 2.08M | 157K | 1.04M | 90K | 202K | 6.33M | 717K | 805K | 4K | 126K | 266K | 346K | 347K | 21.8M | 3.07M | 780K | 34K |
Operating Income | -5.21M | -7.15M | -5.93M | -7.59M | -8.21M | -2.92M | -7.05M | -7.27M | -7.61M | -8.07M | -6.72M | -7.84M | -7.65M | 18.71M | -4.89M | -6.1M | -8.35M |
Interest Income | 163K | 358K | 338K | 419K | 348K | n/a | 409K | 458K | 492K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -7.51M | -7.31M | -7.69M | -7.59M | -11.76M | -4.83M | -9.27M | -9.11M | -9.28M | -9.66M | -7.83M | -7.81M | -7.64M | 18.71M | -4.89M | -6.09M | -7.35M |
Net Income | -8.22M | -7.31M | -7.69M | -7.59M | -11.76M | -4.83M | -9.27M | -9.11M | -9.28M | -8.59M | -7.83M | -7.79M | -7.64M | 18.71M | -4.89M | -6.09M | -7.35M |
Selling & General & Admin | 2.82M | 3.06M | 2.84M | 3.08M | 2.82M | 2.95M | 2.64M | 3.13M | 3.16M | 3.17M | 2.35M | 2.79M | 3.46M | 3.14M | 2.82M | 2.82M | 2.89M |
Research & Development | 4.46M | 4.24M | 4.13M | 4.6M | 5.59M | 6.29M | 5.13M | 4.95M | 4.45M | 5.03M | 4.64M | 5.43M | 4.54M | 3.84M | 5.15M | 4.06M | 5.49M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 142K | n/a | n/a | n/a | n/a | 24K | 2K | 2K | 2K | 1K | n/a |
Operating Expenses | 7.29M | 7.31M | 6.97M | 7.68M | 8.41M | 9.24M | 7.91M | 8.07M | 7.61M | 8.2M | 6.99M | 8.22M | 7.99M | 6.98M | 7.96M | 6.88M | 8.38M |
Interest Expense | 2.67M | 2.58M | 2.46M | 2.34M | 2.4M | 2.28M | 2.62M | 2.29M | 2.17M | 2.04M | 1.3M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.54M | 7.46M | 6.97M | 7.68M | 8.44M | 9.26M | 7.91M | 8.29M | 7.61M | 8.4M | 6.99M | 8.22M | 7.99M | 6.98M | 7.96M | 6.88M | 8.38M |
Income Tax Expense | 715K | n/a | n/a | n/a | n/a | n/a | -16K | n/a | n/a | -1.07M | n/a | -24K | -2K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 76.92M | 75.85M | 74.75M | 74.73M | 69.85M | 62.4M | 61.98M | 61.65M | 61.17M | 60.41M | 60.19M | 60.1M | 60.06M | 59.67M | 59.47M | 57.75M | 57.04M |
Shares Outstanding (Diluted) | 76.92M | 75.85M | 74.75M | 74.73M | 69.85M | 62.4M | 61.98M | 61.65M | 61.17M | 60.41M | 60.19M | 60.15M | 60.06M | 61.18M | 59.47M | 57.75M | 57.04M |
EPS (Basic) | -0.11 | -0.1 | -0.1 | -0.1 | -0.17 | -0.08 | -0.15 | -0.15 | -0.15 | -0.14 | -0.13 | -0.13 | -0.13 | 0.31 | -0.08 | -0.11 | -0.13 |
EPS (Diluted) | -0.11 | -0.1 | -0.1 | -0.1 | -0.17 | -0.08 | -0.15 | -0.15 | -0.15 | -0.14 | -0.13 | -0.13 | -0.13 | 0.31 | -0.08 | -0.11 | -0.13 |
EBITDA | -4.75M | -4.65M | -5.16M | -5.21M | -9.33M | -2.54M | -6.63M | -6.8M | -7.1M | -7.6M | -6.49M | -7.78M | -7.6M | 18.75M | -4.84M | -6.05M | -8.3M |
EBIT | -4.83M | -4.73M | -5.23M | -5.25M | -9.36M | -2.56M | -6.64M | -6.81M | -7.11M | -7.62M | -6.53M | -7.81M | -7.64M | 18.71M | -4.89M | -6.1M | -8.35M |
Depreciation & Amortization | 85K | 79K | 75K | 44K | 28K | 20K | 16K | 16K | 15K | 22K | 39K | 38K | 46K | 45K | 44K | 44K | 45K |